Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? (2020)
Fonte: European Journal of Pharmacology. Unidades: FORP, FMRP
Assuntos: SEROTONINA, CITOCINAS, COVID-19, INFLAMAÇÃO, FISIOPATOLOGIA
ABNT
COSTA, Luís Henrique Angenendt da e SANTOS, Bruna Maitan e BRANCO, Luiz Guilherme de Siqueira. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?. European Journal of Pharmacology, v. 889, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173629. Acesso em: 02 nov. 2024.APA
Costa, L. H. A. da, Santos, B. M., & Branco, L. G. de S. (2020). Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? European Journal of Pharmacology, 889, 1-7. doi:10.1016/j.ejphar.2020.173629NLM
Costa LHA da, Santos BM, Branco LG de S. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? [Internet]. European Journal of Pharmacology. 2020 ; 889 1-7.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173629Vancouver
Costa LHA da, Santos BM, Branco LG de S. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? [Internet]. European Journal of Pharmacology. 2020 ; 889 1-7.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173629